Catalyst Pharmaceuticals
Price & Volume
Stats
See more52W Range | $14.47-$24.64 |
Market Cap | $2.7B |
Shares Short | 5M |
Financials
See moreRevenue (12 Mos) | $491.7M |
Revenue Growth (YoY) | 28.3% |
Gross Profit (12 Mos) | $421.1M |
Diluted EPS | $1.31 |
News
See moreYahoo Finance • 19 days ago
Catalyst Pharmaceuticals to Report Fourth Quarter and Full-Year 2024 Financial Results on February 26, 2025
Yahoo Finance • last month
Catalyst Pharmaceuticals Receives Prestigious Ranking on Forbes 2025 List of America's Most Successful Mid-Cap Companies
Yahoo Finance • last month
Catalyst Pharmaceuticals Announces Sub-Licensee DyDo Pharma Launched FIRDAPSE® in Japan
Yahoo Finance • 3 months ago
NewAmsterdam Pharma Stock Hits 90-Plus RS Rating
About
CEO | Mr. Richard John Daly M.B.A. |
CFO | Mr. Michael W. Kalb CPA |
Address | 355 Alhambra Circle, Coral Gables, FL, United States, 33134 |
Sector | Healthcare |
Industry | Biotechnology |
Full-Time Employees | 0 |
